Direct determination of the enantiomeric purity of (5S)-3-isopropyl-5-p-toluenesulphonyloxymethyloxazolidin-2-one on a cellulose-based chiral stationary phase. In-process control of a chiral intermediate used in the synthesis of enantiomerically pure beta-blocking agents.
D000319:Adrenergic beta-Antagonists / Q000302:isolation & purification*; D002851:Chromatography, High Pressure Liquid; D007202:Indicators and Reagents; D010080:Oxazoles / Q000302:isolation & purification; D023303:Oxazolidinones; D013056:Spectrophotometry, Ultraviolet; D013237:Stereoisomerism
D000319:Adrenergic beta-Antagonists; D007202:Indicators and Reagents; D010080:Oxazoles; D023303:Oxazolidinones; C055314:3-isopropyl-5-(4-toluenesulfonyloxymethyl)oxazolidin-2-one